Transfusion interventions in critical bleeding requiring massive transfusion: A systematic review

Transfusion Medicine Reviews

Volumn 29, Issue 2, 2015, Pages 127-137

  McQuilten, Zoe K ^a,b   Crighton, Gemma ^b   Engelbrecht, Sunelle ^b   Gotmaker, Robert ^c   Brunskill, Susan J ^d   Murphy, Michael F ^d   Wood, Erica M ^b  

^a Clinical Trials Group Executive   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SOUTHERN HEALTH   (Australia)

^d NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood transfusion; Fibrinogen; Gastrointestinal hemorrhage; Hemorrhage; Injuries; Perioperative; Prothrombin complex concentrate; Recombinant FVIIa

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

BLEEDING; BLOOD TRANSFUSION; CINAHL; COCHRANE LIBRARY; CRYOPRECIPITATE; EMBASE; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PLASMA TRANSFUSION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE TRANSFUSION; UPPER GASTROINTESTINAL BLEEDING; ADVERSE EFFECTS; BLOOD COMPONENT THERAPY; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEMORRHAGE; INTENSIVE CARE; LITERATURE; MEASUREMENT ACCURACY; META ANALYSIS (TOPIC); MORTALITY; MULTIMODALITY CANCER THERAPY; PILOT STUDY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; CRITICAL CARE; DATA ACCURACY; EVIDENCE-BASED MEDICINE; FACTOR VIIA; FEASIBILITY STUDIES; GUIDELINE ADHERENCE; HEMORRHAGE; HUMANS; META-ANALYSIS AS TOPIC; PILOT PROJECTS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; REVIEW LITERATURE AS TOPIC; TREATMENT OUTCOME;

EID: 84927046261     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2015.01.001     Document Type: Review

References (42)

1. National Blood Authority (NBA) Patient blood management guidelines: module 1-critical bleeding/massive transfusion 2011, NBA, Canberra, Australia, [Available at: http://www.blood.gov.au/pbm-module-1. Accessed 17 October 2014].
2. National Health and Medical Research Council (NHMRC) A guideline to the development, evaluation and implementation of clinical practice guidelines 1999, NHMRC, Canberra, Australia, [Available at: https://www.nhmrc.gov.au/guidelines/publications/cp30. Accessed 17 October 2014].
3. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, [Available from www.cochrane-handbook.org]. J.P.T. Higgins, S. Green (Eds.).
4. Shea B.J., Grimshaw J.M., Wells G.A., et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007, 7:10.
5. Villanueva C., Colomo A., Bosch A., et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013, 368(1):11-21.
6. Cotton B.A., Podbielski J., Camp E., et al. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg 2013, 258(4):527-532. [discussion 32-3].
7. Nascimento B., Callum J., Tien H., et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 2013, 185(12):E583-E589.
8. Boffard K.D., Choong P.I., Kluger Y., et al. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. Transfusion 2009, 49(Suppl 5):240S-247S.
9. Hauser C.J., Boffard K., Dutton R., et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010, 69(3):489-500.
10. Dutton R.P., Parr M., Tortella B.J., et al. Recombinant activated factor VII safety in trauma patients: results from the CONTROL trial. J Trauma 2011, 71(1):12-19.
11. Jairath V., Hearnshaw S., Brunskill S.J., et al. Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev 2010, 9:CD006613.
12. Wang J., Bao Y.X., Bai M., et al. Restrictive vs liberal transfusion for upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. World J Gastroenterol 2013, 19(40):6919-6927.
13. Murad M.H., Stubbs J.R., Gandhi M.J., et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010, 50(6):1370-1383.
14. Warmuth M., Mad P., Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012, 56(5):539-548.
15. Wikkelso A., Lunde J., Johansen M., et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev 2013, 8:CD008864.
16. Aguado Romeo M.J., Molina Linde J.M., Villegas Portero R. Appropriate use of recombinant activated factor VII in nonhaemophilic patients. Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/04 2009, Andalusian Agency for Health Technology Assessment (AETSA), Seville.
17. Birchall J., Stanworth S.J., Duffy M.R., et al. Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia. Transfus Med Rev 2008, 22(3):177-187.
18. Levi M., Levy J.H., Andersen H.F., et al. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010, 363(19):1791-1800.
19. Marti-Carvajal A.J., Karakitsiou D.E., Salanti G. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev 2012, 3:CD004887.
20. Nishijima D.K., Zehtabchi S. Evidence-based emergency medicine/critically appraised topic. The efficacy of recombinant activated factor VII in severe trauma. Ann Emerg Med 2009, 54(5):737-744.e1.
21. Simpson E., Lin Y., Stanworth S., et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012, 3:CD005011.
22. Curry N., Hopewell S., Doree C., et al. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care 2011, 15(2):R92.
23. Curry N., Stanworth S., Hopewell S., et al. Trauma-induced coagulopathy-a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice?. Transfus Med Rev 2011, 25(3):217-231.e2.
24. Zehtabchi S., Nishijima D.K. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009, 16(5):371-378.
25. Phan H.H., Wisner D.H. Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: what is the evidence?. Vox Sang 2010, 98(3 Pt 2):395-402.
26. Rajasekhar A., Gowing R., Zarychanski R., et al. Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio. Crit Care Med 2011, 39(6):1507-1513.
27. Johansson P.I., Oliveri R.S., Ostrowski S.R. Hemostatic resuscitation with plasma and platelets in trauma. J Emerg Trauma Shock 2012, 5(2):120-125.
28. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59(1):8-15. [discussion 15-8].
29. Snyder C.W., Weinberg J.A., McGwin G., et al. The relationship of blood product ratio to mortality: survival benefit or survival bias?. J Trauma 2009, 66(2):358-362. [discussion 62-4].
30. Frith D., Davenport R., Brohi K. Acute traumatic coagulopathy. Curr Opin Anaesthesiol 2012, 25(2):229-234.
31. Baraniuk S., Tilley B.C., Del Junco D.J., et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury 2014, 45(9):1287-1295.
32. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340(6):409-417.
33. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4:CD002042.
34. Gray A., Jairath V., Kahan B., et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (trigger): pragmatic, cluster randomised, feasibility trial. Emerg Med J 2014, 31(9):780.
35. Rourke C., Curry N., Khan S., et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012, 10(7):1342-1351.
36. Shakur H., Roberts I., Bautista R., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376(9734):23-32.
37. Schulz K.F., Chalmers I., Hayes R.J., et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273(5):408-412.
38. Juni P., Altman D.G., Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323(7303):42-46.
39. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006] 2006, [Available from http://www.cochrane.org/sites/default/files/uploads/Handbook4.2.6Sep2006.pdf Accessed 17 October 2014]. J.P.T. Higgins, S. Green (Eds.).
40. Guyatt G.H., Sackett D.L., Cook D.J. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1993, 270(21):2598-2601.
41. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17(1):1-12.
42. Moher D., Pham B., Jones A., et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998, 352(9128):609-613.